Mr. Chairman, maybe we should have a hearing in this committee into why the President of the United States will not appoint someone to head the Food and Drug Administration as we are in the middle of a pandemic.
Jordan criticizes Biden for not appointing an FDA head during the pandemic.
Share
More from Jim Jordan
That's definitely a concern that I think probably any American with common sense would have.
If we have to, we'll use subpoenas to get the documents that we think they may not be giving us.
These are difficult times that they’re going through, we understand that, these kind of situations always are, but Max is a good member and colleague and hopefully he’s gonna win reelection.
This action confirms that the platform's fraud prevention measures were not as robust as [ActBlue CEO Regina Wallace-Jones] told Congress. We will continue to demand answers.
Other voices in this conversation
